The authors hypothesized that the progesterone component of some hormone replacement therapies in women is detrimental to cognition. A previous study showed that ovariectomy (ovx) in aged rats enhanced spatial working memory and decreased elevated progesterone levels (H. A. Bimonte-Nelson, R. S. Singleton, C. L. Hunter, et al., 2003) . The current study evaluated whether progesterone administration counteracts these cognitive enhancing effects of ovx. Aged sham and aged ovx rats given progesterone exhibited compromised learning of the working and reference memory components of the task, and made more working memory errors on the latter testing days compared with aged ovx rats not given progesterone. Results suggest that whereas ovx of the aged female rat enhances learning and the ability to handle numerous items of spatial working memory information, progesterone is detrimental to these aspects of performance. These findings may speak to studies in menopausal women which suggest that combination hormone therapies have a negative impact on cognition.
In women, the ovaries gradually cease hormonal function as aging ensues (Timaras, Quay, & Vernadakis, 1995) . Because of such natural ovarian cessation or surgical removal of the ovaries, ovarian hormone output eventually terminates in most women, resulting in very low circulating levels of estrogen and progesterone relative to the younger hormonal state. This loss of ovarian hormones may exacerbate neurodegeneration and subsequent cognitive decline. In support of this hypothesis, studies have shown that women exhibited memory decline after oopherectomy (Sherwin, 1988) and that age of oopherectomy and years since surgery correlated with memory scores (Nappi et al., 1999) .
Several studies have suggested that hormone therapy improves cognitive status in menopausal women and reduces the risk of Alzheimer's disease (for review, see Sherwin, 2003) . However, the issue of hormone therapy has yielded much debate. Indeed, a recent study indicated that the rate of dementia was doubled in women 65 years of age and older who took estrogen-progestin combination therapy compared with women who did not (Shumaker et al., 2003) . Further, estrogen-progesterone therapy did not improve cognition and resulted in worse scores on the test of verbal fluency (Grady et al., 2002) . Although there was no estrogen-only group in the latter study, one report described minor cognitive improvements in an estrogen-only group, but cognitive decline in a group receiving combination estrogen-progesterone (Rice et al., 2000) . It is thus possible that the inclusion of progesterone is detrimental to performance on some cognitive tests. Further support of this tenet is provided by human research showing that administration of progesterone or its metabolites decreased verbal memory scores in young women (e.g., Freeman, Weinstock, Rickels, Sondheimer, & Coutifaris, 1992) .
In a series of studies, we recently found that aged female rats exhibited poorer working and reference memory performance on the water radial-arm maze relative to young female rats Bimonte-Nelson, Singleton, Hunter, et al., 2003) . We have also shown that ovariectomy (ovx) of aged female rats improved levels of maze performance to those of young intact females (Bimonte-Nelson, Singleton, Hunter, et al., 2003) . At initial observation, these findings may appear counterintuitive, given that several studies using young rats found that ovarian hormone deprivation was associated with memory decline. For example, ovx was detrimental to working memory in young rats on the water and land radial-arm mazes, especially on trials with a higher memory load (Bimonte & Denenberg, 1999; Daniel, Roberts, & Dohanich, 1999) . Why might ovx in young rats be detrimental to spatial working memory performance, and ovx in aged rats enhance spatial working memory performance?
The gonadal hormone profile of the intact aged female shams in our aging ovx studies revealed that serum progesterone levels were dramatically higher than those of the intact young females, whereas estrogen levels remained unchanged (Bimonte-Nelson, Singleton, Hunter, et al., 2003) . Many endocrine studies have shown that aged female rats enter a pseudopregnant estropause state, whereby progesterone values become elevated but estradiol levels remain stable (Huang, Steger, Bruni, & Meites, 1978; Wise & Ratner, 1980) . This pseudopregnant state has been associated with poorer spatial cognition (Warren & Juraska, 2000) . Hence, a feasible explanation for the cognitionenhancing effects of ovx in aged female rats is that ovx removed the negative impact of elevated progesterone levels.
The current study is the next in a series from our laboratory investigating ovarian hormone contributions to learning and memory in the aged rat. The aim of this experiment was to address whether the ovarian hormone progesterone affects performance on a spatial working and reference memory task in aged female rats. We hypothesized that progesterone supplementation would reverse the cognition-enhancing effects of ovx in aged female rats. To test this hypothesis, we assessed whether progesterone administration before and during testing affected spatial working and/or reference memory performance in aged ovx rats.
Method

Subjects and Treatment Procedures
Young and aged female rats were tested in the water radial-arm maze. Subjects were 6 young (5-6 months old at test) and 30 aged (21 months old at test) Fisher-344 female rats born and reared at the aging colony of the National Institute on Aging at Harlan Laboratories (Indianapolis, IN). Prior to surgery, rats were acclimated for several weeks, and were pair-housed with a same-age and same-treatment assignment cage mate in a barrier environment at the Medical University of South Carolina animal facility. Rats had ad-lib exposure to food and water and were maintained on a 12-hr light-dark cycle at 80°F (26.7°C), according to National Institute on Aging guidelines for aged rats. All procedures were approved by the local Institutional Animal Care and Use Committee and adhered to National Institutes of Health standards.
Surgical Procedures
All rats were given surgery 2 months before behavioral testing. Rats were anesthetized with an intraperitoneal injection of 7 parts Ketamine (Fort Dodge Animal Health, Fort Dodge, IA) and 2 parts Xylazine (Lloyd Laboratories, Shenandoah, IA). Twenty of the 30 aged rats received ovx. For ovx, bilateral dorsolateral incisions were made in the skin and peritoneum, and the ovaries and tips of the uterine horns were ligatured and removed. The muscle was then sutured and the skin stapled. Sham surgery consisted of only the dorsolateral skin incisions and staple procedures above the hip region. In addition, a small incision was made in the scruff of the neck, and a subcutaneous pocket was created with blunt dissection scissors. For rats receiving progesterone, three progesterone pellets were inserted such that the pellets were not in contact with each other, and the skin was stapled. According to the manufacturer (Innovative Research of America, Sarasota, FL), each progesterone pellet (200 mg, 90-day release) was designed to release a continuous dose of approximately 10 ng/ml. Because three pellets were given to each rat, the circulating progesterone level in each subject receiving pellets was approximately 30 ng/ml progesterone. For rats not receiving pellets, the pocket was left empty and the skin was stapled in the same fashion. Nine of the 20 aged ovx rats received pellets, and 11 of the 20 aged ovx rats received sham pellet surgery. The 10 remaining aged rats stayed intact and received sham surgery. The aged rats were thus divided into three treatment groups: one aged group receiving sham surgery only (aged sham; n ϭ 10), one aged group receiving ovx only (aged ovx; n ϭ 11), and one aged group receiving ovx plus three progesterone pellets (aged ovx PROG; n ϭ 9). The young group also received sham surgery at the same time as the aged rats (n ϭ 6). Hence, the resulting groups were: aged sham, aged ovx, aged ovx PROG, and young sham. Vaginal smears were performed after surgery, before testing ensued, to confirm complete removal of ovarian tissue. As expected, all ovx rats exhibited leukocytic acyclic smears. Approximately 2 months after surgery, rats were tested on the water-escape radial maze. Because the progesterone pellets lasted 90 days, rats continued to receive hormone supplementation throughout behavioral testing.
Radial-Arm Maze Testing
The win-shift radial-arm maze uses water-escape onto a hidden platform as the reinforcer, thereby avoiding food deprivation (Bimonte & Denenberg, 1999 , 2000 Bimonte, Granholm, Seo, & Isacson, 2002; Bimonte, Hyde, Hoplight, & Denenberg, 2000; BimonteNelson, Hunter, Nelson, & Granholm, 2003; Bimonte-Nelson, Singleton, Hunter, et al., 2003; Hyde, Hoplight, & Denenberg, 1998; Hyde, Sherman, & Denenberg, 2000) . The maze had 12 arms, but had 4 arms consistently blocked off to make a symmetrical 8-arm maze (for maze dimensions, see . The maze was constructed of galvanized steel, painted black, and filled with water (room temperature). It had hidden escape platforms with wire mesh tops (hidden approximately 1 cm below the water surface) placed in the ends of 4 of the 8 accessible arms. Each subject had different platform locations that were semirandomly determined, and that remained fixed throughout the experiment. There was never a platform in 3 adjacent arms, nor in the arm from which the rat was released. The testing room had salient extramaze cues that remained constant throughout testing, including a door, cabinets, a row of warming lamps, a solid black panel on a wall, a black-and-white striped panel on the opposite wall, and the experimenter who sat behind the start arm.
A subject was released from the start arm, facing the center, and was given 3 min to locate a platform. If the allotted time expired, the subject was guided to the nearest available platform. Once a platform was found, the subject remained on it for 15 s, and was then returned to its heated home cage for 30 s until its next trial. During the interval, the just-chosen platform was removed from the maze. The rat was then placed again into the start alley and allowed to locate another platform. A daily session consisted of this sequence of events repeated until all four platforms were located. Consequently, for each rat, a daily session consisted of four trials per session, with the number of platformed arms reduced by one on each subsequent trial. Thus, four arms contained platforms on Trial 1, three arms contained platforms on Trial 2, et cetera. This pattern continued so that by Trial 4, only one arm contained a platform. Because one platform was removed after every trial, one more item of information needed to be remembered after every trial. Hence, the working memory system was increasingly taxed as trials progressed. This version is similar to the land version in that the rats had to avoid arms that never contained a reinforcer (reference memory) and enter only once into arms that contained a reinforcer (working memory).
Each subject was given one session a day for 15 days; there was a 2-day break after every 5 days of testing. Day 1 was considered a training session because the rat had had no previous experience in the maze. Days 2-15 were testing sessions, which were divided into the acquisition phase (Days 2-8) and the asymptotic phase (Days 9 -15). Behavioral testing took place between 0900 and 1400. An arm entry was counted when the tip of a rat's snout reached a mark delineated on the outside of the arm that was not visible from the inside of the maze (11 cm into the arm). Errors were quantified for each daily session using the orthogonal measures of working and reference memory errors (Jarrard, Okaichi, Steward, & Goldschmidt, 1984) , as was done previously in studies using the water-escape radial-arm maze (Bimonte et al., , 2002 Bimonte-Nelson, Singleton, Hunter, et al., 2003; Hyde et al., 2000) . Working memory correct errors were the number of first and repeat entries into any arm from which a platform had been removed during that session. Reference memory errors were the number of first entries into any arm that never contained a platform. Working memory incorrect errors were the number of repeat entries into an arm that never contained a platform (thus, repeat entries into a reference memory arm).
For working memory correct and incorrect, the data for each phase were analyzed with a 1 Between (age or treatment) ϫ 2 Within (days and trials) repeated measures analysis of variance (ANOVA). Trial 1 was not included in the working memory correct analysis because it is not possible to make a working memory correct error on the first trial. For reference memory, each phase was analyzed with a 1 Between (age or treatment) ϫ 1 Within (days) repeated measures ANOVA. Because the direction of the effect was known, one-tailed tests were used for all young sham versus aged sham comparisons. Two-tailed tests were used for all other analyses.
Results
Effects of Aging
Before investigating our new findings, it was first necessary to ensure that we replicated our previous age effects on the water radial-arm maze. As we have shown in a prior study (BimonteNelson, Singleton, Hunter, et al., 2003) , aged shams performed worse than young shams on all three orthogonal memory measures (see Figure 1) . Collapsed across trials, aged shams made more working memory correct, F(1, 14) ϭ 7.35, p Ͻ .05, and reference memory, F(1, 14) ϭ 4.69, p Ͻ .05, errors during the latter portion of testing, on Days 9 -15. Aged rats also made more working memory incorrect errors during the acquisition phase, F(1, 14) ϭ 3.42, p Ͻ .05, and marginally more working memory incorrect errors during the asymptotic phase, F(1, 14) ϭ 2.36, p ϭ .07, than young shams. As trials progressed and working memory load increased, aged rats made disproportionately more errors, as shown in the Age ϫ Trials interaction (see Figure 2) for working memory incorrect, F(3, 42) ϭ 2.40, p Ͻ .05, and marginally more for working memory correct, F(2, 28) ϭ 1.99, p ϭ .08.
Effects of OVX and Progesterone Treatment in Aged Rats
As we have shown in previous studies (Bimonte-Nelson, Singleton, Hunter, et al., 2003) , repeated measures ANOVAs revealed that aged ovx rats made fewer working memory correct, F(1, 20) ϭ 8.88, p Ͻ .01, and working memory incorrect, F(1, 20) ϭ 4.43, p Ͻ .05, errors than aged sham rats during the asymptotic phase of testing (Figure 1 ). In addition, as graphically demonstrated in Figure 2 , aged rats that received ovx were better able to handle an increasing memory load compared with aged sham rats, as demonstrated by the OVX ϫ Trial interactions for working memory correct, F(2, 40) ϭ 3.36, p Ͻ .05, and working memory incorrect, F(3, 60) ϭ 4.84, p Ͻ .005. Aged ovx rats did not differ from aged sham rats on reference memory for either phase, nor did these two groups differ on working memory correct or incorrect during the acquisition phase. Further evaluations showed that aged ovx rats did not differ from young shams on any working memory measure, suggesting that ovx enhanced working memory performance to that of young rats.
Progesterone administration counteracted the beneficial effects of ovx. Indeed, as revealed by the repeated measures ANOVA comparing the aged ovx PROG group to the aged ovx group, during the asymptotic phase, aged ovx rats given progesterone made more working memory correct, F(1, 19) ϭ 12.93, p Ͻ .005, and working memory incorrect, F(1, 19) ϭ 7.49, p Ͻ .05, errors compared with aged ovx rats given no hormone (Figure 1 ). Progesterone administration was also detrimental to the ability of ovx rats to handle an increasing working memory load ( Figure 2) ; the Treatment ϫ Trial interactions showed that as working memory load increased, aged ovx PROG rats made more working memory correct, F(2, 38) ϭ 9.73, p Ͻ .0005, and working memory incorrect, F(3, 57) ϭ 7.85, p Ͻ .0005, errors than aged ovx rats. Aged ovx rats and aged ovx PROG rats did not differ on reference memory for either phase. There were also no differences between these two groups for working memory correct or incorrect during the acquisition phase.
Evaluation of Individual Differences in Aged Rats: Learners Versus Nonlearners
To evaluate which subjects exhibited learning, we determined which subjects showed a significant decrease in errors from the Young sham rats performed better than aged sham rats on all three orthogonal working and reference memory measures. Ovariectomy (Ovx) in aged rats enhanced performance on the two working memory measures, whereas progesterone (P) counteracted the beneficial effects of ovx.
# p Ͻ .10, *p Ͻ .05, **p Ͻ .01, ***p Ͻ .005. acquisition to the asymptotic testing phase . For this analysis, we collapsed across trials and days for each subject to obtain a mean score for the acquisition phase and a mean score for the asymptotic phase. We used a one-way t test to determine whether there was a significant decrease in errors from one phase to the next. Figure 3 depicts the mean scores for the acquisition phase and the asymptotic phase for each subject, and Table 1 shows the significance value of the t test for each subject. A significant value indicates that there was a significant decrease in errors from the acquisition to the asymptotic phase, suggesting that the subject learned.
Of the three aged groups, the aged ovx group exhibited the highest percentage of subjects that showed a significant change from one phase to the next for working memory correct, reference memory, and working memory incorrect. This thereby suggests that the aged ovx group had the highest percentage of subjects that learned each measure. Furthermore, for every memory measure, the majority of the aged ovx subjects learned, whereas the majority of the aged sham and aged ovx PROG subjects did not learn (see Table 1 and Figure 4) . Notably, for working memory correct, 7 of the 11 (64%) aged ovx rats showed a significant decrease in errors, whereas this decrease was only seen in 2 of the 10 (20%) aged sham and 1 of the 9 (11%) aged ovx PROG rats. For reference memory, 8 of the 11 (73%) aged ovx rats showed a significant change from one phase to the next, whereas only 3 of the 10 (30%) aged sham and 5 of the 11 (45%) aged ovx PROG rats showing a significant change. For working memory incorrect, 9 of the 11 (82%) aged ovx rats showed a decrease in errors across phase, whereas 2 of the 10 (20%) aged sham rats and 2 of the 11 (18%) aged ovx PROG rats showed a decrease in errors across phase. It is also noteworthy that the aged ovx group had the highest percentage of subjects that learned all three measures. Indeed, 6 of the 11 (55%) aged ovx rats learned all three measures, whereas only 2 of the 10 (20%) aged sham rats and 1 of the 9 (11%) aged ovx PROG rats learned all three measures (Table 1) . Figure 3 . Line graphs representing the decrease in working memory correct, reference memory, and working memory incorrect errors from the acquisition phase (Days 2-7) to the asymptotic phase (Days 8 -15) for each aged subject, categorized by treatment group. The bold lines represent subjects that exhibited learning, which was operationally defined as a significant decrease in errors from the acquisition to the asymptotic phase. Compared with aged sham rats and aged ovariectomized (Ovx) rats given progesterone (Prog), aged ovx rats not given progesterone had the highest percentage of subjects that exhibited learning. Note. Aged ovariectomized (ovx) rats showed the highest percentage of subjects that learned each measure as compared with aged sham rats and aged ovx ϩ progesterone rats. WMC ϭ working memory correct; RM ϭ reference memory; WMI ϭ working memory incorrect. Boldface indicates significant testing phase comparisons ( p Ͻ .05), and pound signs indicate marginal testing phase comparisons (# p Ͻ .10).
Discussion
We have previously shown that ovx in young rats compromises, and ovx in aged rats enhances, working memory performance on the water radial-arm maze (Bimonte & Denenberg, 1999; Bimonte-Nelson, Singleton, Hunter, et al., 2003) . We postulated that the ovx-induced improvements in maze performance in aged rats were a result, in part, of the removal of elevated progesterone levels. Hence, we hypothesized that progesterone has negative effects on cognition in aged female rats. We tested this hypothesis in the current study by evaluating whether progesterone supplementation counteracted the performance-enhancing effects of ovx in aged rats. Supporting our hypothesis, we now report that aged ovx rats given progesterone exhibited more working memory errors and compromised learning of working and reference memory measures compared with aged ovx rats not given progesterone.
It is intriguing that ovx, and ovx plus progesterone, treatments affected the same maze parameters. Specifically, the main effects analysis of errors showed that ovx was beneficial to, and progesterone was detrimental to, performance on working memory correct and incorrect measures during the latter testing phase, with no effects on reference memory (Figure 1 ). In addition, on both orthogonal working memory measures, ovx was beneficial, and progesterone supplementation was detrimental, to performance as working memory load increased (Figure 2 ). These findings suggest that removal of the ovaries improves the ability of aged female rats to handle numerous items of working memory information, whereas progesterone supplementation impairs this ability.
To assess individual differences in the learning of each measure, we evaluated whether there was a significant decrease in scores between the initial acquisition and the latter asymptotic phases of testing. Again, compared with aged sham rats and aged ovx rats given progesterone, aged ovx rats without progesterone exhibited the best performance, with the highest percentage of subjects that learned each working and reference memory measure. Collectively, our data suggest that ovx enhances the ability of aged female rats to learn the working and reference memory components of a maze task (Figure 3 and Table 1 ), as well as improves the ability to remember spatial working memory information (Figures 1 and 2 ). Our findings also indicate that progesterone is detrimental to each of these aspects of performance, counteracting the enhancing effects of ovx. Hence, removal of elevated progesterone levels may be one mechanism whereby ovx in aged female rats improves cognitive performance.
Several animal studies correspond with our findings that progesterone is detrimental to cognitive performance. Indeed, administration of progesterone or its metabolite, allopregnanolone, impaired performance on spatial working and reference memory tasks and avoidance tasks in young adult rats and mice (Farr et al., 1995; Frye & Sturgis, 1995; Johansson, Birzniece, Lindblad, Olsson, & Backstrom, 2002) . Like the effects of estrogen, progesterone's effects on cognition appear to be influenced by many factors, including level of circulating hormone (e.g., Bimonte & Denenberg, 1999; Holmes, Wide, & Galea, 2002; Nyborg, 1984;  for discussion, see Fitch & Bimonte, 2001 ). We (Bimonte-Nelson, Singleton, Hunter, et al., 2003) and others (Huang et al., 1978; Wise & Ratner, 1980) have shown that aged female rats enter a pseudopregnant estropause state, whereby progesterone values become elevated but estradiol levels remain stable. This state of elevated progesterone levels has been associated with poorer spatial cognition (Warren and Juraska, 2000) . Correspondingly, in young cycling rats, spatial reference memory performance was worse during the proestrus phase, when estrogen and progesterone levels are highest, and best during the estrus phase, when estrogen and progesterone are lowest (Warren & Juraska, 1997 ; but see Berry, McMahan, & Gallagher, 1997; Stackman, Blasberg, Langan, & Clark, 1997) . As discussed previously (Warren & Juraska, 2000) , in both young cycling and aged estropausal rats, those in the phases with the highest progesterone levels performed the poorest relative to their age group. Research in young women has also shown that spatial skills are weakest during the midluteal phase, when estrogen and progesterone levels are higher, and strongest during menstruation, when estrogen and progesterone levels are lower (Hampson, 1990a (Hampson, , 1990b . It should also be noted that progesterone and its metabolites have been shown to reduce or increase anxiety depending on circulating or hippocampal hormone concentrations, an effect which may, in turn, influence performance on cognitive tasks (Frye, Petralia, & Rhodes, 2000; Frye & Walf, 2002; Gomez, Saldivar-Gonzalez, Delgado, & Rodriguez, 2002) .
Many additional factors appear to play a role in progesterone's effects on cognition. Indeed, there is evidence that progesterone influences estradiol's effects, and that gonadal hormone effects might interact with age. In aged female rats, progesterone enhanced estradiol's effects on a spatial delayed match-to-position task (Gibbs, 2000) . Further, estrogen plus progesterone facilitated spatial reference memory performance in aged female rats (Markham, Pych, & Juraska, 2002 ). Yet, in contrast, in young female rats, estrogen plus progesterone impaired spatial reference memory performance (Chesler & Juraska, 2000) . Because in this prior study neither estradiol nor progesterone alone had effects, the interaction of estradiol and progesterone was responsible for the deficits. Other studies in young rodents have shown that progesterone enhanced conditioned avoidance performance at the estrous, but not diestrous, phase, again suggesting that baseline hormonal status influences progesterone's effects (Diaz-Veliz, Urresta, Dussaubat, & Mora, 1994) . Additional critical factors potentially influencing progesterone's effects on spatial cognition include mode of administration (Frye & Sturgis, 1995) and time after administration (Johansson et al., 2002) .
It is also likely that baseline brain status at the time of hormone administration has an impact on progesterone's effects. Research evaluating models of acute neurodegeneration (e.g., experimentally induced brain injury) have shown that progesterone treatment improved spatial reference memory performance and reduced neuronal loss after cortical injury in young animals (Roof, Duvdevani, Braswell, & Stein, 1994) . These and other (e.g., Roof, Duvdevani, & Stein, 1993) findings suggest that in some cases, progesterone protects against brain injury and the consequences thereof, at least in young animals. The hormone-manipulated rats in our study were aged and thus had presumably undergone some neurodegenerative processes. However, neural damage caused by aging is distinct from acute, experimentally-induced neural insults whereby progesterone had neuroprotective effects. Whether various doses of progesterone protect the aged brain from acute injury remains to be determined in future studies. Further, given that progesterone can both positively and negatively influence cognition, future studies evaluating the specific parameters of progesterone's effects in aged and young animals, alone and in conjunction with estradiol, will yield a better understanding of these complex effects.
The cognitive effects of ovx (e.g., comparing an ovx group to an intact sham group) have been evaluated in young and aged animals. In young rodents, ovx impairs spatial working memory performance on the water or land radial-arm maze, and improves spatial reference memory performance on the Morris maze (Bimonte & Denenberg, 1999; Daniel et al., 1999) . Research evaluating the effects of ovx in aged animals is limited. As far as we are aware, aside from our current and previous (Bimonte-Nelson, Singleton, Hunter, et al., 2003) studies, there is only one other study using aged rats that has compared ovx subjects to those that have remained intact. The other investigation was a longitudinal study showing that 4 months of ovx in 17-month-old Fisher rats was detrimental to delayed nonmatch-to-sample performance, although ovx had no effect on spatial reference memory (Markowska & Savonenko, 2002) . In agreement with our findings, a recent study reported that aged ovx monkeys outperformed aged intact monkeys on the spatial condition of the delayed recognition span test (Lacreuse, Herndon, & Moss, 2000) . Because the monkeys in that study underwent ovx early in life, the authors suggested that long-term removal of ovarian hormones may protect against age-related spatial memory deficits (Lacreuse et al., 2000) .
It is unclear how the findings from animal studies relate to studies evaluating cognitive effects of hormone loss and replacement in menopausal women. Indeed, in contrast to our findings that ovx in aged female rats is beneficial to cognitive scores, older women who received oopherectomy exhibited a decrease in verbal memory scores (for review, see Sherwin, 1998 , or Sherwin, 2003 . In agreement, Nappi et al. (1999) found that time since oopherectomy correlated with verbal memory scores, with a longer period of ovarian hormone loss associated with worse performance. It is likely that the discrepancy between studies in aged rats and in older women are related to the differences in age-related hormone alterations.
There are both similarities and differences in age-related alterations of the reproductive system of women and female rats. In women, estrogen and progesterone levels decrease with age as menopause proceeds, eventually resulting in dramatically lower hormone levels compared with those in young women (Timiras et al., 1995) . In contrast, in female rats, estradiol levels remain stable while progesterone levels increase as age and estropause ensue. Hence, although in both women and animal models, age-related hormonal changes likely contribute to age-related cognitive decline, the hormonal alterations are in divergent directions. In women, the hormonal changes associated with age may be detrimental to cognitive performance as a result of the reduction of "optimal" hormone levels that are circulating in young women, whereas hormone loss by ovx in aged rats may be beneficial to cognitive performance as a result of removal of the negative impact of elevated progesterone levels.
As a result of the discrepancies between age-associated changes in the ovarian hormone profile of the rat versus the woman, it is important to limit extrapolation to relationships between specific hormones and cognitive scores rather than the cognitive status of the older ovary-intact estropausal rat to the older ovary-intact menopausal woman. In this light, our findings suggesting that progesterone is detrimental to working memory in the aged rat may speak to recent findings in menopausal women that estrogenprogesterone combination therapies negatively influence cognition and Alzheimer's disease risk, whereas estrogen alone may not result in these negative effects (Grady et al., 2002; Rice et al., 2000; Shumaker et al., 2003) . The progesterone component of combination hormone replacement therapy may contribute to some of the reported negative effects on cognition. Although some human research has addressed this question (e.g., Rice et al., 2000) , few studies in women have directly compared hormone replacement therapies with and without progesterone. Findings in the current and previous reports (Bimonte-Nelson, Singleton, Hunter, et al., 2003) add to the accumulating literature identifying progesterone as a potentially crucial factor that influences the cognitive outcome of hormone treatment. Future research is necessary in order to identify hormone replacement therapies that incorporate the benefits of unopposed (estrogen-only) therapy with the minimum effective dose of progesterone that is necessary to successfully reduce the risk of reproductive cancers.
Most research evaluating hormonal effects on cognitive brain regions has focused specifically on estrogenic actions (e.g., Farr, Banks, & Morley, 2000; Miller et al., 1999) . Hence, as yet there is limited information on whether progesterone also has effects upon these systems. There is increasing evidence, however, that some neurobiological parameters may be differentially influenced by estradiol versus progesterone, and that progesterone may counteract estradiol's effects under some circumstances. Indeed, estrogen, but not progesterone, protected against glutamate toxicity in cortex (Singer, Rogers, Strickland, & Dorsa, 1996) . Another study evaluating protection against glutamate insult showed that some progestin preparations enhanced neuroprotection initiated by estrogen, whereas another counteracted estrogen's effects (Nilsen & Brinton, 2002) . In young female rats, hippocampal spine density was decreased by ovx, and increased to control levels by estradiol treatment (Gould, Woolley, Frankfurt, & McEwen, 1990; Woolley & McEwen, 1992 ). Yet, estradiol plus progesterone treatment did not yield an increase in dendritic spine density as did estradiol alone (Gould et al., 1990; Woolley and McEwen, 1992) . Thus, progesterone decreased the efficacy of estradiol's effects on this aspect of the hippocampus, a brain region known to be intimately linked to spatial learning and memory.
Finally, it is clear that age-related hormonal changes affect the brain and cognition in the aging human and nonhuman mammal. Yet, age-associated circulating hormone alterations are probably not the only factor influencing changes in hormone-behavior relationships with age. In fact, as aging ensues, estrogen and progesterone receptor concentrations become altered (Mills, Romeo, Lu, & Micevych, 2002; Wise & Parsons, 1984) , and there is evidence that receptor responsiveness to hormone administration becomes attenuated (Funabashi et al., 2000) . These and other factors may result in an altered response to circulating hormones in aged organisms, in turn producing a dynamic, complex cascade of interactions that depend on hormone levels as well as number, affinity, and responsiveness of hormone receptors.
In conclusion, the current findings indicate that progesterone is detrimental to spatial cognition in aged female rats. These data suggest that removal of elevated progesterone levels contributes to the observed ovx-induced cognitive enhancement in aged rats. Our results may relate to recent studies in menopausal women suggesting that some hormone replacement therapies have a negative impact on cognitive status. Progesterone is a necessary component of hormone replacement therapy in women with an intact uterus. Thus, future research to determine the specific cognitive and neural effects of progesterone, alone and in conjunction with estrogen, is necessary and crucial to the understanding and clarification of the complex effects of ovarian hormone loss and ovarian hormone replacement.
